IP Library › Granted Patent US 12,376,616
Granted Patent B2
US 12,376,616 · App. 17/415,740 · Granted Aug 5, 2025

Protein compositions with high isoelectric proteins

Inventors: Vaida Urbonaite-Zuke (Utrecht, NL); Aveenash Bala (Utrecht, NL)
Assignee: N.V. Nutricia
A23L33/19A23C9/1216A23C11/06A23C21/04A23C21/06A23C21/08A23L29/06A23L33/185A23L33/40A23V2250/54242A23V2250/54244A23V2250/54246A23V2250/54252A23V2250/5428A23V2250/548
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,376,616
App. No.
17/415,740
Granted
Aug 5, 2025
Kind
B2
Abstract

The present invention is in the field of protein compositions, in particular protein compositions for infant milk formula. The protein compositions according to the invention comprise whey protein, casein and high isoelectric point proteins, such as those having an isoelectric point of at least 6.0. The present invention further relates to the uses of the protein compositions.

Claims (14)

1. A composition comprising casein, whey protein and at least one high isoelectric protein from a non-dairy source, said high isoelectric protein having an isoelectric point of between 6.0 and 11, wherein the weight ratio of the sum of casein and whey protein to the high-isoelectric protein in the composition is between 95:5 and 75:25, wherein the composition is an infant formula comprising 0.8-3.0 g/100 ml protein when in liquid form.

2. The composition according to claim 1 , wherein the casein and whey protein are present in a weight ratio between 30:70 and 70:30.

3. The composition according to claim 1 , wherein the casein comprises β-caseins in an amount of between 35 and 60 wt. % of total casein content; and/or wherein the casein comprises α-caseins in an amount of between 20 and 60 wt. % of total casein content; and/or wherein the casein comprises k-caseins in an amount of between 15 and 30 wt. % of total casein content.

4. The composition according to claim 1 , wherein the whey protein comprises α-lactalbumin in an amount of between 20 and 80 wt. % of total whey protein content; and/or wherein the whey protein comprises β-lactoglobulin in an amount of between 20 and 70 wt. % of total whey protein content.

5. The composition according to claim 1 , wherein the high isoelectric protein is one or more proteins selected from the group consisting of lysozyme, ovotransferrin, canola protein, rapeseed protein, or mixtures thereof.

6. The composition to according to claim 1 , wherein the at least one high isoelectric protein is in intact form.

7. The composition according to claim 1 , wherein only one high isoelectric protein having an isoelectric point between 9.0 and 11 is present.

8. The composition according to claim 1 , wherein the composition comprises two high isoelectric proteins from a non-dairy source having an isoelectric point between 6.0 and 11, wherein one of the isoelectric proteins has an isoelectric point between 9.0 and 11.

9. The composition according to claim 1 , consisting of casein, whey protein and at least one high isoelectric protein, including one high isoelectric protein from a non-dairy source.

10. A composition comprising casein, whey protein and at least one high isoelectric protein from a non-dairy source, said high isoelectric protein having an isoelectric point of between 6.0 and 11, wherein the weight ratio of the sum of casein and whey protein to the high-isoelectric protein in the composition is between 95:5 and 75:25, wherein the composition is an infant formula, wherein the infant formula comprises lipid, protein and digestible carbohydrates, with 5 to 20 energy % protein, based on total calories provided by the composition, and wherein the infant formula comprises 50 to 90 kcal/100 ml when in liquid form.

11. The composition according to claim 10 , wherein the infant formula comprises 60 to 70 kcal/100 ml when in liquid form.

12. A composition comprising casein, whey protein and at least one high isoelectric protein from a non-dairy source, said high isoelectric protein having an isoelectric point of between 6.0 and 11, wherein the weight ratio of the sum of casein and whey protein to the high-isoelectric protein in the composition is between 95:5 and 75:25, wherein the composition is an infant formula in liquid form, comprising 0.8-3.0 g/100 ml protein.

13. A composition comprising casein, whey protein and at least one high isoelectric protein from a non-dairy source, said high isoelectric protein having an isoelectric point of between 6.0 and 11, wherein the weight ratio of the sum of casein and whey protein to the high-isoelectric protein in the composition is between 95:5 and 75:25, wherein the composition is an infant formula in liquid form, wherein the infant formula comprises lipid, protein and digestible carbohydrates, with 5 to 20 energy % protein, based on total calories provided by the composition, and wherein the infant formula comprises 50 to 90 kcal/100 ml when in liquid form.

14. The composition according to claim 13 , wherein the infant formula comprises 60 to 70 kcal/100 ml liquid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2022
From: URBONAITE-ZUKE, VAIDA; BALA, AVEENASH
To: N.V. NUTRICIA
Reel/Frame 059467/0379 →
Priority Claims (1)
WO PCT/NL2018/050883 · Dec 21, 2018 · international
Continuity (1)
Related Publication 20210378279A1 · Dec 9, 2021
References Cited (72)
US 3338719A · Sawada · 1967 [cited by examiner]
US 5436020A · Kuwata · 1995 [cited by examiner]
US 6190724B1 · Sawatzki · 2001 [cited by applicant]
US 8580316B2 · Boehm et al. · 2013 [cited by applicant]
US 11154081B1 · Lele · 2021 [cited by examiner]
US 20050175622A1 · Edens · 2005 [cited by examiner]
US 20060286086A1 · Ferrari · 2006 [cited by examiner]
US 20070092629A1 · Scanlin · 2007 [cited by examiner]
US 20100233318A1 · Edens · 2010 [cited by examiner]
US 20120135103A1 · Walsh · 2012 [cited by examiner]
US 20120171164A1 · Wittke et al. · 2012 [cited by applicant]
US 20120269929A1 · Lippman · 2012 [cited by examiner]
US 20130089572A1 · Vanderhoof · 2013 [cited by examiner]
US 20130129707A1 · Murata · 2013 [cited by examiner]
US 20150305359A1 · Ao · 2015 [cited by examiner]
US 20170099852A1 · Nono et al. · 2017 [cited by applicant]
US 20190069589A1 · Smulders · 2019 [cited by examiner]
US 20190216106A1 · Geistlinger · 2019 [cited by examiner]
US 20200260773A1 · Ao · 2020 [cited by examiner]
US 20200359650A1 · Shi · 2020 [cited by examiner]
US 20210161172A1 · Gee · 2021 [cited by examiner]
US 20220000161A1 · Cakir-Fuller · 2022 [cited by examiner]
US 20220071899A1 · Jaecklein · 2022 [cited by examiner]
US 20240196949A1 · Kapeleris · 2024 [cited by examiner]
AU 2007216827B2 · 2012 [cited by applicant]
CN 108813632A · 2018 [cited by applicant]
EP 2441443A1 · 2012 [cited by applicant]
WO 9915024A1 · 1999 [cited by applicant]
WO 2005017168A1 · 2005 [cited by applicant]
WO WO2016174651A2 · 2016 [cited by examiner]
WO 2018039632A1 · 2018 [cited by applicant]
Chiu et al, Direct Purification of Lysozyme from Chicken Egg White Using Weak Acidic Polyacrylonitrile Nanofiber-Based membranes, https://onlinelibrary.wiley.com/doi/epdf/10.1002/app.36764 (Year: 2012). [cited by examiner]
Translation of CN 105746713A (Year: 2016). [cited by examiner]
Satoru Oshima et al.: Efficacy of Organic Acids, Bacteriocins, and the Lactoperoxidase System in Inhibiting the Growth of [cited by applicant]
Database FSTA [Online], International Food Information Service (IFIS), Frankfurt-Main, DE; Ming-Jiang Zhang et al.: “Development of a new lysozyme adding technology in infant formula”, XP002794350, Database accession No… [cited by applicant]
S A Al-Mashdchi et al.: “Separation of Ovotransferrin from Egg White by Immobilized Metal Affinity Chromatography”, Agric. Biol. Chem, Jan. 1, 1987 (Jan. 1, 1987), pp. 2881-2887, XP055623241, Retrieved from the Internet… [cited by applicant]
Wu Jianping et al.: “Ovotransferrin: Structure, bioactivities, and preparation”, Food Research International, vol. 46, No. 2, 2012, pp. 480-487, XP028905410, ISSN: 0963-9969, DOI: 10.1016/J.FOODRES.2011.07.012, p. 480; … [cited by applicant]
Hans Demmelmair et al.: Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants, Nutrients, vol. 9, No. 8. Jul. 28, 2017 (Jul. 28, 2017), pp. 1-22, XP055616883, DOI: 10.3390/nu9080817 paragraph [… [cited by applicant]
Mattias Fredrikson et al: Production Process for High-Quality Pea-Protein Isolate with Low Content of Oligosaccharides and Phytate, Journal of Agricultural and Food Chemistry, vol. 49, No. 3, Jan. 31, 2001 (Jan. 31, 200… [cited by applicant]
Nguyen: Digestibility and structural changes of ingredients in infant formulae during the gastrointestinal digestion, PhD thesis, The University of Queensland, School of Agriculture and Food Sciences—published: 2017. [cited by applicant]
Martin et al.: Review of Infant Feeding: Key Features of Breast Milk and Infant Formulae. Nutrients 2016, 8, 279—published: 2016. [cited by applicant]
Lonnerdal: Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr 2014; 99 (suppl): 712S-7S—published: 2014. [cited by applicant]
Maathuis et al.: Protein Digestion and Quality of Goat and Cow Milk Infant Formula and Human Milk Under Simulated Infant Conditions. JPGN 2017: 65:6, 661-666—published: 2017. [cited by applicant]
Aly et al.: Supplementation of infant formulas with recombinant human lactoferrin and/or galactooligosaccharides increases iron bioaccessibility as measured by ferritin formed in Caco-2 cell model. Food Research Interna… [cited by applicant]
Brock: Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. Archives of Disease in Childhood, 1980, 55, 417-421—published: 1980. [cited by applicant]
Panfil-Kuncewicz et al.: Influence of lysozyme on the enzymatic coagulation of milk. Acta Alimentaria Polonica. Vol. XIV (XXXVIII), No. 3-4, 145-152—published: 1988. [cited by applicant]
Dairy UK: Milk—Nutrition information for all the family—published: Jan. 2018. [cited by applicant]
Panfil-Kuncewicz et al.: Influence of lysozyme on changes in size of casein micelles in milk. Acta Alimentaria Polonica, vol. XIV (XXXVIII), No. 3-4, 153-161—published: 1988. [cited by applicant]
Anema et al.: Interaction of Lactoferrin and Lysozyme with Casein Micelles. Biomacromolecules 12, 3970-3976—published: 2011. [cited by applicant]
Product Bulletin: Skimmilk powder—Regular, Low Heat, GDT Specification, Fonterra New Zealand—Version Feb. 5, 2024—published: 2024. [cited by applicant]
Thompson et al.: Nomenclature of the proteins of cow's milk—second revision. Report of the Committee on Milk Protein Nomenclature, Classification, and Methodology of the Manufacturing Section of ADSA for 1963-64—publish… [cited by applicant]
Demmelmair et al.: Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants. Nutrients 2017, 9, 817—published: 2017. [cited by applicant]
Lonnerdal: Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003: 77 (suppl): 1537S-43S—published: 2003. [cited by applicant]
Brand et al.: A novel approach for lysozyme and ovotransferrin fractionation from egg white by radial flow membrane adsorption chromatography: Impact of product and process variables. Separation and Purification Technol… [cited by applicant]
Dupont: Protein requirements during the first year of life. Am J Clin Nutr 2003; 77 (suppl): 1544S-9S—published: 2003. [cited by applicant]
Dallas et al.: Digestion of Protein in Premature and Term Infants. Nutr Disorders Ther 2012, 2, 3—published 2012. [cited by applicant]
Del Giacco et al.: Total IgE in newborns treated prophylactically with conalbumin. Int. J. Tiss. Reac. VII (6) 535-537—published 1985. [cited by applicant]
Hay Jr. et al.: Preterm formula use in the preterm very low birth weight infant. Seminars in Fetal & Neonatal Medicine 22 (2017) 15-22—published: 2017. [cited by applicant]
Wanasundara et al.: Canola/rapeseed protein-functionality and nutrition. Ocl, Edp Sciences, 2016. [cited by applicant]
Bethell, “Generally Recognized as safe (GRAS) notification for lysozyme (human) from rice for use as an ingredient in infant and pre-term formulas and in pediatric medical foods”. GRAS notification submitted with the FD… [cited by applicant]
Excerpt from Mintel; “Stage 1 Baby Formula” from Namyang Dairy Products, published Mar. 2018. [cited by applicant]
Newburg, “Bioactive components of human milk”, 2001, pp. 15 and 241. [cited by applicant]
Guo, “Human Milk Biochemistry and Infant formula Manufacturing Technology”, 2014, p. 20. [cited by applicant]
Packard, “Human milk and infant formula”, 1982, pp. 83-86. [cited by applicant]
Parry et al., “Isolation and Characterization of human milk lysozyme”, Arch Biochem and Biophys, 1969, 103, pp. 59-65. [cited by applicant]
Gonzalez-Chavez et al., “Lactoferrin : structure, function and applications”, Int J Antim Agents, 2009, 33, pp. 301. e1-301.e8. [cited by applicant]
Anema, “Spontaneous interaction of lactoferrin with casein micelles or individual caseins”—2018. [cited by applicant]
Kailasapathy 2015. Chemical Composition, Physical, and Functional Properties of Milk and Milk Ingredients. In Dairy Processing and Quality Assurance (eds R.C. Chandan, A. Kilara and N.P. Shah). [cited by applicant]
Pang, Z. et al., “Evaluation of tilapia skin gelatin as a mammalian gelatin replacer in acid milk gels and low-fat stirred yogurt”—2017. [cited by applicant]
Schorsch, C., et al., “Cross-linking casein micelles by a microbial transglutaminase conditions for formation of transglutaminase-induced gels”—2000. [cited by applicant]
Organic Chemistry 4th ed—2000. [cited by applicant]
Commission Delegated Regulation (EU) 2016/127. [cited by applicant]